Journals / Güncel Pediatri / 2009 / Cilt: 7 - Sayı: 3

Lung functions during long term follow-up after pleural empyema treatment in children

Çocuklarda plevral ampiyem tedavisi sonrası uzun süreli izlemde akciğer fonksiyonları

Pages
117–124
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our results suggest that lung functions are not significantly compromised at long term after empyema treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Studies on lung functions at the long term follow-up of pleural empyema treatment in children are limited.
📊
Key Findings & Data:The aim of this study was to evaluate the long term pulmonary function test results in childhood empyema cases treated with antibiotic (AB) or AB+tube thoracostomy (TT) or AB+TT+fibrinolytics (FT).Materials and Method: In this study, 45 cases (1 to 13 years old) treated for empyema were included.
💡
Conclusion & Impact:Our results suggest that lung functions are not significantly compromised at long term after empyema treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Studies on lung functions at the long term follow-up of pleural empyema treatment in children are limited. The aim of this study was to evaluate the long term pulmonary function test results in childhood empyema cases treated with antibiotic (AB) or AB+tube thoracostomy (TT) or AB+TT+fibrinolytics (FT).Materials and Method: In this study, 45 cases (1 to 13 years old) treated for empyema were included. The age, gender, clinical characteristics, radiological findings and laboratory results at baseline and during the follow-up periods and the treatment modalities (AB or AB+TT or AB+TT+FT) were evaluated. Pulmonary function tests were performed at the end of the follow-up periods.Results: The mean ages at baseline and at the end of follow-up period of 30.4±13.5 (6-54) months were 6.3±3.3 (1-13) years and 9.3±3.4 (4-17) years, respectively. Stages of the disease at admission was acute exudative (stage 1) in 14 (31.1%) cases, fibrinopurulent (stage 2) in 19 (42.2%) and chronic organizing (stage 3) in 12 (26.7%). Twenty one cases (46.7%)were treated with AB, 8 (17.8%) with AB+TT and 16 (35.5%) with AB+TT+FT. Chest roentgenograms showed abnormal findings in 15 cases (33.3%) at the 3rd month, in 3 cases (6.6%) at the 6th month and none at the 12th month. Pulmonary function tests were available in 25 children. The mean follow-up period of these cases was 32.7±11.9 months after the empyema treatment. Three cases (12%) with a shorter mean follow-up (8.3±3.3 months) had minimal restrictive patterns. Six of 25 (24%) cases having pulmonary function tests were classified as stage 1, 12 (48%) as stage 2, and 7 (28%) as stage 3 empyema at admission. Of 25 cases having pulmonary function tests, 12 (48%) were treated with AB, 4 (16%) with AB+TT and 9 (36%) with AB+TT+FT. Mean VC, FVC, FEV1/FVC, FEV1, FEF25-75% and PEF values did not significantly differ according to stages and treatment modalities (p>0.05). Conclusion: It was seen that after the treatment of empyema, remarkable improvements were seen in chest roentgenographic findings between 3rd and 6th months and in general, pulmonary function tests revealed normal results in long term. Our results suggest that lung functions are not significantly compromised at long term after empyema treatment.

Özet

Giriş: Çocukluk çağında ampiyem tedavisi sonrası uzun süreli izlemde akciğer fonksiyonlarının değerlendirilmesi ile ilgili çalışmalar az sayıdadır. Bu çalışmada ampiyemli çocuklarda antibiyotik (AB) veya antibiyotik + tüp torakostomi (TT) veya AB+TT+fibrinolitik (FT) tedavileri sonrası geç dönem solunum fonksiyon testleri sonuçlarının araştırılması amaçlandı. Gereç ve Yöntem: Ampiyem nedeniyle 1-13 yaşlarında tedavi edilmiş 45 olgu çalışmaya alındı. Hastaların yaş, cinsiyet, başlangıç ve izlem süresince saptanan klinik bulguları, radyoloji ve laboratuvar sonuçları, uygulanan tedaviler (AB veya AB+TT veya AB+TT+FT) incelendi. İzlem süreleri sonunda solunum fonksiyon testleri yapılarak değerlendirildi. Bulgular: Olguların ortalama yaşları ilk başvuruda 6,3±3,3 yaş (1-13 yaş), izlem süresi sonunda ortalama 9,3±3,4 yaş (4-17 yaş), ortalama izlem süreleri 30,4±13,5 ay (6-54 ay) olarak bulundu. İlk başvurularında ampiyemli olguların 14’ü (%31,1) akut eksudatif evre (Evre 1), 19’u (%42,2) fibropürülan evre (Evre 2) ve 12’si (%26,7) kronik organize evre (Evre 3) olarak sınıflandırılmıştı. Yirmi bir (%46,7) olgu AB, 8 (%17,8) olgu AB+TT ve 16 (%35,5) olgu da AB+TT+FT tedavisi almıştı. İzlem süresinde akciğer grafilerinde 3. ayda 15 (%33,3), 6. ayda 3 (%6,6) olguda patolojik bulgu bulundu, 12. ayda tamamı normaldi. Yirmibeş olguya solunum fonksiyon testleri yapılabildi. Bu olguların ortalama izlem süreleri 32,7±11,9 ay idi. Yirmibeş olgunun 3’ünde (%12) minimal restriktif bulgular saptandı, bu 3 olgunun izlem süreleri daha kısa idi (8,3±3,3 ay). Solunum fonksiyon testleri yapılan 25 olgudan 6’sı (%24) Evre 1, 12’si (%48) Evre 2, 7’si (%28) Evre 3 ampiyem olarak sınıflandırılmıştı ve 12 olgu (%48) AB, 4 olgu (%16) AB+TT, 9 olgu (%36) AB+TT+FT tedavisi almıştı. Evrelere ve tedavi yöntemlerine göre olguların VC, FVC, FEV1/FVC, FEV1, FEF25-75% ve PEF değerleri ortalamaları karşılaştırıldığında gruplar arasında istatistiksel anlamlı farklılıklar bulunmadı (p>0,05). Sonuç: Çocuklarda ampiyem tedavisi sonrası izlem süresinde 3.- 6. aylar arasında akciğer grafilerinde belirgin düzelmenin gözlendiği ve geç dönemde solunum fonksiyon testlerinin genel olarak normal sınırlar içinde olduğu belirlendi. Sonuçlarımız çocuklarda ampiyem tedavisi sonrası uzun dönemde akciğer fonksiyonlarında belirgin bir bozulma gelişmediğini düşündürmektedir.

🔖

Cite This Article

HACIMUSTAFAOĞLU, M., CANITEZ, Y., KIRKPINAR, A., GÜRPINAR, A., SAPAN, N., ÇELEBİ, S. (2022). Lung functions during long term follow-up after pleural empyema treatment in children. Güncel Pediatri, Cilt: 7 - Sayı: 3, 117–124. https://ajindex.com/articles/528088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Oak SN, Parelkar SV, Satishkumar KV, Pathak R, Ramesh BH, Sudhir S et al. Review of video-assisted thoracoscopy in children. J Minim Access Surg 2009; 5:57-62
  2. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004; 113:701-7
  3. Satish B, Bunker M, Seddon P. Management of thoracic empyema in childhood: does the pleural thickening matter? Arch Dis Child 2003; 88:918-21
  4. Jaffé A, Balfour-Lynn IM. Management of empyema in children. Pediatr Pulmonol 2005; 40:148-56
  5. American Thoracic Society. Management of non-tuberculous empyema. Am Rev Respir Dis 1962; 85:935-6
  6. Balfour-Lynn IM, Abrahamson E, Cohen G, Hartley J, King S, Parikh D et al. BTS guidelines for the management of pleural infection in children. Thorax [Suppl] 2005; 60:1-21
  7. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004; 59:522-5
  8. Kurt BA, Winterhalter KM, Connors RH, Betz BW, Winters JW. Therapy of parapneumonic effusions in children: Video-Assisted Thoracoscopic Surgery versus conventional thoracostomy drainage. Pediatrics 2006; 118:547-53
  9. Göçmen A, Kiper N, Toppare M, Ozcelik U, Cengizlier R, Cetinkaya F. Conservative treatment of empyema in children. Respiration 1993; 60:182-5
  10. Redding GJ, Walund L, Walund D, Jones JW, Stamey DC, Gibson RL. Lung function in children following empyema. AJDC 1990;144: 1337-42
  11. Soto M, Demis T, Landau LI. Pulmonary function following staphylococcal pneumonia in children. Aust Paediatr J 1983; 19:172-4
  12. Kohn GL, Walston C, Feldstein J, Warner BW, Succop P, Hardie WD. Persistent abnormal lung function after childhood empyema. Am J Respir Med 2002; 1:441-5
  13. Wise MB, Beaudry PH, Bates DV. Long-term follow-up of staphylococcal pneumonia. Pediatrics 1966; 38:398-401
  14. McLaughlin FJ, Goldmann DA, Rosenbaum DM, Harris GB, Schuster SR, Strieder DJ. Empyema in children: clinical course and long-term follow-up. Pediatrics 1984; 73:587-93
  15. Murphy D, Lockhart CH, Todd JK. Pneumococcal empyema outcome of medikal management. Am J Dis Child 1980; 134:659-62
  16. Hoff SJ, Neblett WW, Heller RM, Pietsch JB, Holcomb GW Jr, Sheller JR et al. Postpneumonic empyema in childhood: selecting appropriate therapy. J Pediatr Surg 1989; 24:659-64
  17. Montgomery M. Air and liquid in the